GeneDx Ownership | Who Owns GeneDx?


OverviewForecastRevenueFinancialsChartTranscripts

GeneDx Ownership Summary


GeneDx is owned by 56.06% institutional investors, 27.00% insiders, and 16.94% retail investors. Corvex management lp is the largest institutional shareholder, holding 12.00% of WGS shares. ARK Innovation ETF is the top mutual fund, with 2.80% of its assets in GeneDx shares.

WGS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockGeneDx56.06%27.00%16.94%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryHealthcare Information Services Stocks 33.98%12.11%53.90%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Corvex management lp3.23M12.00%$207.31M
Casdin capital3.01M11.18%$193.12M
Blackrock funding, inc. /de1.55M5.77%$99.59M
Westfield capital management co lp1.37M5.09%$87.92M
Goldman sachs group1.33M4.96%$85.73M
Ark investment management1.32M4.93%$85.06M
Vanguard group1.19M4.13%$154.65M
Oracle investment management922.45K3.23%$85.15M
William blair investment management775.27K2.88%$49.79M
Zweig-dimenna associates689.29K2.56%$44.27M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Oracle investment management922.45K58.40%$85.15M
Casdin capital3.01M14.62%$193.12M
Alamea verwaltungs gmbh185.99K8.85%$11.94M
Corvex management lp3.23M8.24%$207.31M
Gagnon advisors148.22K7.00%$9.52M
Zweig-dimenna associates689.29K6.13%$44.27M
Prosight management, lp523.46K5.51%$33.62M
Gagnon securities303.15K4.49%$19.47M
Science & technology partners241.20K4.05%$15.49M
Palisades investment partners92.00K2.32%$5.91M

Top Buyers

HolderShares% AssetsChange
Ark investment management1.32M0.66%720.02K
Prosight management, lp523.46K5.51%468.46K
Citadel advisors647.40K0.01%465.05K
Eventide asset management459.01K0.49%459.01K
Westfield capital management co lp1.37M0.37%350.85K

Top Sellers

HolderShares% AssetsChange
Pentwater capital management lp425.00K0.26%-795.00K
Fmr295.62K0.00%-537.12K
T. rowe price investment management86.08K0.00%-498.07K
Franklin resources607.22K0.01%-485.77K
Lord, abbett42.65K0.01%-475.66K

New Positions

HolderShares% AssetsChangeValue
Eventide asset management459.01K0.49%459.01K$29.47M
Vestal point capital, lp250.00K0.45%250.00K$16.05M
First light asset management242.93K1.40%242.93K$15.60M
Abrdn230.10K0.02%230.10K$14.78M
Vanguard fiduciary trust144.46K0.00%144.46K$9.28M

Sold Out

HolderChange
Assetmark-1.00
Gps wealth strategies group-1.00
Mather group, llc.-2.00
Tortoise investment management-2.00
Nemes rush group-3.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026155-49.68%15,076,123-51.36%560.48%83-45.03%49-53.33%
Dec 31, 2025233-19.93%20,170,201-32.99%700.63%118-24.36%78-8.24%
Sep 30, 202528216.53%29,207,814-0.14%1020.98%1513.42%8450.00%
Jun 30, 20252481.64%31,311,68210.33%1091.08%146-0.68%60-1.64%
Mar 31, 202524215.24%28,417,95020.78%1001.34%144-4.64%6272.22%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
ARK Innovation ETF831.22K2.80%-60.63K
ARK Disruptive Innovation Full Composite822.41K2.77%470.61K
Vanguard Total Stock Mkt Idx Inv599.47K2.02%-
American Funds SMALLCAP World A459.49K1.55%66.34K
iShares Russell 2000 ETF447.38K1.51%3.76K
ARK Genomic Revolution ETF401.29K1.35%16.98K
Invesco Discovery A395.55K1.33%16.59K
Invesco OFI Small Cap Growth395.55K1.33%35.10K
Amova ARK Disruptive Innovation A USD369.92K1.25%10.32K
ARK Genomic Revolution350.20K1.18%172.18K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 09, 2026Feeley Kevin CHIEF FINANCIAL OFFICERSell$68.07K
Jun 09, 2026Stueland Katherine CHIEF EXECUTIVE OFFICERSell$195.67K
Jun 05, 2026Casdin Capital, LLC Buy$2.64M
Jun 04, 2026Casdin Capital, LLC Buy$8.47M
May 19, 2026Casdin Capital, LLC Buy$7.88M

Insider Transactions Trends


DateBuySell
2026 Q2275
2026 Q11038
2025 Q4-43
2025 Q3-39
2025 Q2537

WGS Ownership FAQ


Who Owns GeneDx?

GeneDx shareholders are primarily institutional investors at 56.06%, followed by 27.00% insiders and 16.94% retail investors. The average institutional ownership in GeneDx's industry, Healthcare Information Services Stocks , is 33.98%, which GeneDx exceeds.

Who owns the most shares of GeneDx?

GeneDx’s largest shareholders are Corvex management lp (3.23M shares, 12.00%), Casdin capital (3.01M shares, 11.18%), and Blackrock funding, inc. /de (1.55M shares, 5.77%). Together, they hold 28.95% of GeneDx’s total shares outstanding.

Does Blackrock own GeneDx?

BlackRock is not among the top 10 institutional shareholders of GeneDx.

Who is GeneDx’s biggest shareholder by percentage of total assets invested?

Oracle investment management is GeneDx’s biggest shareholder by percentage of total assets invested, with 58.40% of its assets in 922.45K GeneDx shares, valued at 85.15M$.

Who is the top mutual fund holder of GeneDx shares?

ARK Innovation ETF is the top mutual fund holder of GeneDx shares, with 2.80% of its total shares outstanding invested in 831.22K GeneDx shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools